1,024 material Form 8-K filings that 799 companies we cover made with the SEC in August 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
EPAM reported second-quarter 2025 revenue of $1.353 billion, up 18.0% year over year, and raised its full-year 2025 revenue growth outlook to 13.0% to 15.0%. GAAP diluted earnings per share fell 8.2% to $1.56, while non-GAAP diluted EPS rose 13.1% to $2.77, so shareholders see higher sales and a raised revenue outlook alongside lower GAAP profit per share.
Q2 2025 revenue was $1.353 billion, up 18.0%; organic constant currency revenue rose 5.3%.
GAAP diluted EPS was $1.56, down from $1.70 (down 8.2%); non-GAAP diluted EPS was $2.77, up 13.1% from $2.45.
Full-year 2025 revenue growth outlook raised to 13.0% to 15.0%; organic constant currency growth outlook is 3.0% to 5.0%.
Third-quarter 2025 revenue is expected in the range of $1.365 billion to $1.380 billion.
Ziff Davis reported unaudited second-quarter 2025 results, with revenue up 9.8% to $352.2 million and GAAP net income down 28.6% to $26.3 million. The company reaffirmed its full-year 2025 guidance, including revenue of $1,442 million to $1,502 million and adjusted diluted EPS of $6.64 to $7.28, and will discuss the results on an August 7, 2025 call.
Q2 2025 revenue rose 9.8% to $352.2 million; income from operations rose 17.2% to $33.5 million.
GAAP net income fell to $26.3 million from $36.9 million, and GAAP diluted EPS fell to $0.62 from $0.77.
Adjusted diluted EPS rose 5.1% to $1.24 from $1.18; adjusted EBITDA rose 11.8% to $107.7 million.
FY2025 guidance reaffirmed: revenue $1,442 million to $1,502 million, adjusted EBITDA $505 million to $542 million.
Kinetik reported second quarter 2025 results, with total operating revenues of $426.7 million, up from $359.5 million a year earlier, and Adjusted EBITDA of $242.9 million, up from $234.4 million. Net income including noncontrolling interest fell to $74.4 million from $108.9 million, and diluted earnings per share were $0.33 versus $0.54, so shareholders see higher sales alongside lower GAAP profit. The company updated its 2025 Adjusted EBITDA guidance to $1.03 billion to $1.09 billion and narrowed its capital guidance to $460 million to $530 million.
Total operating revenues were $426.7 million versus $359.5 million in Q2 2024; net income including noncontrolling interest was $74.4 million versus $108.9 million.
Diluted earnings per share attributable to Class A holders were $0.33 versus $0.54 in the prior-year quarter.
2025 Adjusted EBITDA guidance updated to $1.03 billion to $1.09 billion; full-year capital guidance narrowed to $460 million to $530 million.
Kings Landing full commercial in-service is expected in late September 2025; Kinetik has repurchased $172.6 million of Class A stock year to date.
Talos Energy reported second-quarter 2025 results on August 6, 2025, with a net loss of $185.9 million that included a $223.9 million non-cash impairment charge. The company also improved its full-year 2025 guidance, citing higher production, lower operating expenses and lower capital expenditures, and reported $357.3 million of cash at June 30, 2025.
Net loss of $185.9 million, or $1.05 per diluted share, including a $223.9 million non-cash ceiling test impairment; adjusted net loss of $48.3 million, or $0.27 per share
Total revenues of $424.7 million, Adjusted EBITDA of $294.2 million and net cash from operating activities of $351.6 million for the quarter
Full-year 2025 production guidance revised to 91.0 to 95.0 MBoe/d from 90.0 to 95.0 MBoe/d; cash operating expenses and workovers guidance lowered to $555 million to $585 million
Repurchased 3.8 million shares for $32.6 million in the quarter; net debt of $892.7 million and net debt to LTM Adjusted EBITDA of 0.7x at June 30, 2025
CF Industries reported second-quarter 2025 net sales of $1,890 million, up from $1,572 million a year earlier, while net earnings attributable to common stockholders fell to $386 million from $420 million. Diluted earnings per share rose to $2.37 from $2.30, with a lower diluted share count of 163.1 million versus 182.8 million, and adjusted EBITDA edged up to $761 million from $752 million.
Q2 2025 net sales $1,890 million vs $1,572 million in Q2 2024
Net earnings attributable to common stockholders $386 million vs $420 million; diluted EPS $2.37 vs $2.30
Q2 2025 adjusted EBITDA $761 million vs $752 million; 1H 2025 adjusted EBITDA $1,405 million, up 16%
Over $800 million returned to shareholders in 1H 2025 through repurchases and dividends; ~$425 million left in $3 billion repurchase authorization
Chord Energy reported a second-quarter 2025 net loss of $389.9 million, or $6.77 per diluted share, after a $539.3 million non-cash goodwill impairment that reduced goodwill to zero. Adjusted net income was $103.2 million ($1.79 per diluted share), down from $234.9 million in the second quarter of 2024, while the company raised its full-year 2025 oil production guidance and lowered its capital spending guidance, and declared a $1.30 per share base dividend.
Q2 2025 net loss of $389.9 million ($6.77 per diluted share); Adjusted EBITDA of $547.2 million versus $567.9 million in Q2 2024
Non-cash goodwill impairment charge of $539.3 million, reducing goodwill to zero as of June 30, 2025
FY25 oil production guidance raised 500 barrels per day at midpoint to 153.0 MBopd; E&P and other CapEx lowered $20 million to $1.35 billion at midpoint
Base dividend of $1.30 per share payable September 8, 2025; new $1 billion share repurchase program authorized
Helmerich & Payne reported a fiscal third-quarter net loss of $163 million, or $1.64 per share, compared with net income of $0.01 per share in the prior quarter, after a $173 million non-cash goodwill impairment. Excluding this and other one-time items, earnings were $22 million, or $0.22 per share, and revenue rose to $1.04 billion from $1.02 billion in the prior quarter. The company also raised its fiscal 2025 gross capital expenditure estimate to $380-$395 million.
Q3 fiscal 2025 net loss of $163 million, or $1.64 per diluted share, versus $0.88 per diluted share in the year-earlier quarter
Operating revenues of $1.04 billion, up from $1.02 billion in the prior quarter
Q4 fiscal 2025 North America Solutions direct margin guidance of $230-$250 million
Term loan repayment expected to total $200 million by end of calendar 2025, up from the prior $175 million expectation
F&G Annuities & Life reported second quarter 2025 results on August 6, 2025. Revenue rose to $1.36 billion from $1.17 billion a year earlier, but net earnings to common shareholders fell to $35 million, or $0.26 per diluted share, and adjusted net earnings fell to $103 million, or $0.77 per share. The mixed results show higher sales and revenue alongside lower profit for shareholders.
Net earnings to common shareholders were $35 million, or $0.26 per diluted share, versus $198 million, or $1.55 per share, in Q2 2024.
Adjusted net earnings were $103 million, or $0.77 per share, versus $139 million, or $1.10 per share, in Q2 2024.
Total revenues were $1.36 billion, up from $1.17 billion; gross sales were $4.1 billion and AUM before flow reinsurance was $69.2 billion, up 13%.
Book value per common share excluding AOCI was $43.39 at June 30, 2025; the company will hold a conference call on August 7, 2025 at 9:00 a.m. Eastern Time.
Fidelity National Financial reported second-quarter 2025 net earnings attributable to common shareholders of $278 million, or $1.02 per diluted share, down from $306 million, or $1.12, a year earlier. Adjusted net earnings were $318 million, or $1.16 per share, compared with $338 million, or $1.24, while total revenue rose to $3.6 billion from $3.2 billion. The results show higher revenue alongside lower profit, with the company also citing repurchases of 2.9 million shares for $159 million and $135 million in dividends during the quarter.
Total revenue was $3,635 million, compared with $3,158 million in the second quarter of 2024.
Adjusted pre-tax title margin was 15.5%, versus 16.2%, with elevated health claims and higher investments in security, technology and recruiting cited.
F&G Segment net earnings were $33 million, compared with $171 million, due to unfavorable mark-to-market movement; adjusted net earnings were $89 million versus $122 million.
FNF will host a conference call on Thursday, August 7, 2025, at 11:00 a.m. Eastern Time.
Global Net Lease reported second-quarter 2025 revenue of $124.9 million, down from $145.5 million a year earlier, mainly due to asset dispositions including the multi-tenant retail portfolio sale. The company narrowed its net loss attributable to common stockholders to $35.1 million from $46.6 million and raised the low end of its 2025 AFFO per share guidance to a range of $0.92 to $0.96.
Revenue was $124.9 million versus $145.5 million in second quarter 2024, primarily reflecting asset dispositions.
Net loss attributable to common stockholders was $35.1 million, or $0.16 per diluted share, versus $46.6 million, or $0.20 per share, a year earlier.
AFFO was $53.1 million, or $0.24 per share, versus $76.7 million, or $0.33 per share, in second quarter 2024.
The low end of 2025 AFFO per share guidance was raised to a new range of $0.92 to $0.96; the Net Debt to Adjusted EBITDA range of 6.5x to 7.1x was reaffirmed.
Deluxe reported second quarter 2025 revenue of $521.3 million, down 3.1% from a year earlier, while net income rose 9.3% to $22.4 million. The company affirmed its 2025 revenue, adjusted EBITDA, and adjusted diluted EPS guidance and raised its free cash flow range to $130 million to $150 million, which matters to shareholders because it signals stronger expected cash generation even as sales decline.
Revenue was $521.3 million versus $537.8 million a year earlier; comparable adjusted revenue fell 2.5%.
Net income was $22.4 million versus $20.5 million; diluted EPS was $0.50 versus $0.46.
Comparable adjusted diluted EPS rose 3.5% to $0.88, and comparable adjusted EBITDA rose 4.6% to $106.5 million.
Full-year free cash flow outlook was raised to between $130 million and $150 million; a $0.30 quarterly dividend is payable September 2, 2025.
Crane NXT reported second-quarter 2025 sales of $404.4 million, up 9.1% from a year earlier, driven mainly by acquisitions and favorable foreign exchange, with core sales down 0.8%. GAAP earnings per diluted share fell to $0.43 from $0.72, and the company kept its full-year adjusted EPS guidance of $4.00 to $4.30, so shareholders see higher sales alongside lower reported profit.
Q2 2025 net sales $404.4 million, up $33.8 million or 9.1% year over year; core sales declined 0.8%
GAAP operating profit $47.9 million versus $67.6 million; GAAP EPS $0.43 versus $0.72; adjusted EPS $0.97 versus $1.06
Full-year 2025 adjusted EPS guidance of $4.00 to $4.30 maintained, as given on May 7, 2025
Quarterly dividend of $0.17 per share declared, payable September 10, 2025, to holders of record as of August 29, 2025
On August 5, 2025, e.l.f. Beauty completed its acquisition of rhode for $800 million, including $600 million in cash funded by a new $600 million term loan and about $200 million in company stock. For the quarter ended June 30, 2025, net sales rose 9%, but GAAP net income fell to $33.3 million from $47.6 million and gross margin declined to 69% amid tariff costs, so shareholders face a larger debt load and a mixed quarterly picture.
rhode acquisition closed August 5, 2025: $800 million aggregate consideration, with up to $200 million more in earn-out payments tied to rhode revenue over three years
Q1 fiscal 2026 net sales rose 9% to $353.7 million; GAAP net income was $33.3 million versus $47.6 million, and GAAP diluted EPS was $0.58 versus $0.81
Gross margin decreased about 215 basis points to 69%, primarily due to tariffs; the company is not giving a full-year fiscal 2026 outlook
New $600 million term loan matures March 3, 2030; the revolving credit facility unused-commitment fees and interest margins were increased
Acadia Pharmaceuticals reported second-quarter 2025 total revenue of $264.6 million, up 9% from a year earlier, driven by growth in NUPLAZID and DAYBUE sales. Net income fell to $26.7 million, or $0.16 per share, because the effective tax rate rose, and the company raised the low end of its 2025 NUPLAZID sales guidance and its total revenue guidance.
Total revenue was $264.6 million, up 9% from $242.0 million in the second quarter of 2024.
Net income was $26.7 million, or $0.16 per diluted share, versus $33.4 million, or $0.20 per share, a year earlier.
Full-year 2025 total revenue guidance low end raised to $1.045 billion from $1.030 billion; NUPLAZID net sales guidance low end raised to $665 million; other guidance reiterated.
Top-line results from the COMPASS PWS Phase 3 study of ACP-101 are expected in early Q4 2025.
Central Garden & Pet reported fiscal third-quarter 2025 results for the period ended June 28, 2025. Net sales fell 4% to $961 million, while GAAP diluted earnings per share rose to $1.52 from $1.19, helped by gross margin expansion from its Cost and Simplicity program. The company reaffirmed its fiscal 2025 non-GAAP EPS outlook of approximately $2.60.
Net sales were $961 million, down 4%; Pet segment sales fell 3% and Garden segment sales fell 4%.
GAAP diluted EPS was $1.52 vs. $1.19 a year earlier; non-GAAP diluted EPS was $1.56 vs. $1.32.
Gross margin expanded 280 basis points to 34.6%; the company repurchased 1.7 million shares for $55 million in the quarter.
Fiscal 2025 non-GAAP EPS outlook of approximately $2.60 was reaffirmed, not changed.
Primerica reported second-quarter 2025 results, with total revenue of $793.3 million and GAAP diluted EPS of $5.40, down from $6.07 from continuing operations a year earlier. Adjusted diluted operating EPS rose 10% to $5.46, but the year-earlier GAAP figure included a $50 million insurance claim gain that the company excludes from its adjusted measures.
Total revenue was $793.3 million versus $791.0 million in Q2 2024; net income was $178.3 million.
Diluted adjusted operating EPS was $5.46, up 10% from $4.95; adjusted operating revenues rose 7% to $796.0 million.
Term Life adjusted direct premiums rose 5%; ISP product sales were $3.5 billion, up 15%.
The company repurchased $129 million of common stock and declared a $1.04 per share dividend payable September 15, 2025.
Topgolf Callaway Brands reported second quarter 2025 net revenue of $1,110.5 million, down 4.1% year over year, and GAAP net income of $20.3 million, down 67.3%. The company raised its full year 2025 Adjusted EBITDA guidance for continuing businesses to $430 million to $490 million, after completing the sale of Jack Wolfskin on May 31, 2025, which lowered its forecast revenue and EBITDA.
Q2 net revenue was $1,110.5 million, down 4.1%, mainly due to lower Active Lifestyle revenue after the Jack Wolfskin sale; GAAP diluted EPS was $0.11 versus $0.32 a year earlier
Non-GAAP diluted EPS was $0.24 versus $0.42, and Adjusted EBITDA was $195.8 million, down 4.8%
Full year 2025 Consolidated Adjusted EBITDA guidance is $430 million to $490 million, versus $415 million to $505 million previously; consolidated net revenue guidance is $3.80 billion to $3.92 billion following the Jack Wolfskin exclusion
Topgolf CEO Artie Starrs announced his resignation on July 31; he will remain through September 2025, and a Topgolf spin-off is likely not until 2026
EnerSys reported first-quarter fiscal 2026 net sales of $893.0 million, up 4.7%, and adjusted diluted EPS of $2.08, up 5%, while GAAP diluted EPS fell to $1.46 from $1.71. The Board also approved a new $1 billion share repurchase authorization over five years and raised the quarterly dividend 9% to $0.2625 per share, which matters to shareholders because it adds capacity for buybacks and higher cash payouts. The company paused full-year quantitative guidance.
Net sales of $893.0 million, up 4.7%, above the $830 million to $870 million first-quarter guidance range given May 21, 2025
GAAP diluted EPS of $1.46 versus $1.71 a year earlier; adjusted diluted EPS of $2.08 versus $1.98, within the $2.03 to $2.13 guidance range
Board approved a $1 billion repurchase authorization over five years and a dividend of $0.2625 per share payable September 26, 2025, to holders of record as of September 12, 2025
Second-quarter fiscal 2026 outlook: net sales of $870 million to $910 million and adjusted diluted EPS of $2.33 to $2.43; full-year quantitative guidance remains paused
Tandem Diabetes reported second quarter 2025 worldwide sales of $240.7 million, up from $221.9 million a year earlier, but its GAAP net loss widened to $52.4 million from $30.8 million, including a $20.0 million litigation and settlement expense. The company also gave full-year 2025 guidance of about $1.0 billion in sales and a 53% to 54% gross margin, which matters to shareholders because it sets the company's expected revenue and margin path for the year.
Q2 2025 worldwide sales were $240.7 million, including $70.5 million outside the United States, compared with $221.9 million in Q2 2024.
GAAP net loss per share was $0.78, compared with $0.47 a year earlier; GAAP operating loss was $51.8 million.
2025 guidance calls for about $1.0 billion in sales, with about $700 million in the United States and about $300 million outside it.
Adjusted EBITDA margin for 2025 was recast from about 3% to about negative 5%, reflecting an 8 percentage point impact from a first quarter acquired in-process research and development charge.
Texas Pacific Land Corporation reported second-quarter 2025 net income of $116.1 million, or $5.05 per diluted share, and total revenues of $187.5 million, both down from the first quarter of 2025. For the six months ended June 30, 2025, net income rose to $236.8 million from $229.0 million a year earlier, and the Board declared a $1.60 per share quarterly dividend payable September 16, 2025.
Q2 2025 total revenues were $187.5 million, versus $196.0 million in Q1 2025; net income was $116.1 million, versus $120.7 million.
Easements and other surface-related income rose to $36.2 million from $18.2 million in Q1 2025, while produced water royalties were $30.7 million.
Six-month total revenues were $383.5 million, up from $346.5 million for the same period of 2024.
Quarterly dividend of $1.60 per share is payable September 16, 2025, to holders of record on September 2, 2025.
Occidental reported second-quarter 2025 net income attributable to common stockholders of $288 million, or $0.26 per diluted share, down from $766 million, or $0.77 per share, in the first quarter. Adjusted earnings were $0.39 per diluted share, and the company reduced the mid-point of its 2025 capital guidance by $100 million and international operating costs by $50 million. For shareholders, lower earnings are offset in part by production above the mid-point of guidance and $3.0 billion of debt repaid year-to-date.
Net income of $288 million, or $0.26 per diluted share, versus $766 million, or $0.77, in the first quarter of 2025; adjusted earnings of $0.39 per diluted share
Total production of 1,400 Mboed, above the mid-point of guidance; oil and gas pre-tax income of $934 million
Operating cash flow of $3.0 billion and free cash flow before working capital of $0.7 billion; $3.0 billion of debt repaid year-to-date
2025 capital guidance mid-point reduced by $100 million and international operating costs by $50 million
Permian Resources reported second-quarter 2025 results on August 6, 2025. Oil and gas sales were $1.2 billion and diluted EPS was $0.28, both lower than a year earlier, while average production rose to 385,118 Boe/d from 338,761 Boe/d. The company raised its 2025 production guidance midpoint to 385.0 MBoe/d, and shareholders should weigh higher output against lower sales and earnings.
Diluted EPS was $0.28 versus $0.36 a year earlier; net income attributable to Class A Common Stock was $207.1 million versus $235.1 million.
Oil and gas sales were $1.2 billion ($1,197.6 million) versus $1.2 billion ($1,246.1 million) in the second quarter of 2024.
Average production was 385,118 Boe/d versus 338,761 Boe/d; 2025 production guidance midpoint was raised to 385.0 MBoe/d.
Board declared a $0.15 per share base dividend payable September 30, 2025; the company repurchased $43 million of stock at $10.52 per share.
Power Integrations reported second-quarter 2025 revenue of $115.9 million, up 9% from a year earlier, but GAAP net income fell to $1.4 million, or $0.02 per diluted share, after a $9.2 million employment litigation charge. Non-GAAP diluted EPS was $0.35, and the company guided third-quarter revenue to $118 million plus or minus $5 million.
Q2 2025 net revenues were $115.9 million, up 9% year over year and up 10% from the first quarter.
GAAP diluted EPS was $0.02, compared with $0.09 in Q2 2024; non-GAAP diluted EPS was $0.35, compared with $0.28.
Q3 2025 guidance: revenue of $118 million plus or minus $5 million; GAAP gross margin of 54.5% to 55%.
The company repurchased 706 thousand shares for $32.6 million in Q2 and had $42.4 million left on its authorization at quarter-end.
Protagonist Therapeutics reported its second quarter 2025 results, with license and collaboration revenue of $5.5 million, up from $4.2 million a year earlier, while its net loss widened to $34.8 million, or $0.55 per share, from $30.6 million, or $0.50 per share. Cash, cash equivalents and marketable securities totaled $673.0 million at June 30, 2025, which the company expects to fund operations through at least the end of 2028.
Q2 2025 license and collaboration revenue was $5.5 million, compared with $4.2 million in Q2 2024, all from development services under the Takeda collaboration.
Q2 2025 net loss was $34.8 million, or $0.55 per basic and diluted share, versus a net loss of $30.6 million, or $0.50 per share, in Q2 2024.
Cash, cash equivalents and marketable securities were $673.0 million at June 30, 2025, up from $559.2 million at December 31, 2024.
Icotrokinra NDA for plaque psoriasis was filed with the FDA in July 2025; the rusfertide U.S. NDA for polycythemia vera is expected in Q4 2025.
National Health Investors reported second-quarter 2025 results with diluted EPS of $0.79, down from $0.81 a year earlier, while normalized FFO per diluted share rose to $1.22 from $1.18. The company lowered its 2025 NAREIT FFO per diluted share guidance to $4.46-$4.50 from $4.64-$4.70 but raised its normalized FFO and normalized FAD guidance, and it expects an $8.8 million reduction in third-quarter rental income tied to the Discovery lease termination.
Diluted EPS was $0.79 versus $0.81 in the prior-year quarter, including $1.3 million of proxy contest expenses.
Normalized FFO per diluted share was $1.22 versus $1.18; NAREIT FFO per diluted share was $1.19 versus $1.18.
2025 NAREIT FFO per diluted share guidance was lowered to $4.46-$4.50 from $4.64-$4.70; normalized FFO guidance was raised to $4.78-$4.82 from $4.68-$4.73.
Discovery Senior Living lease was terminated effective August 1, 2025, with an expected $8.8 million third-quarter rental income reduction.
Pursuit reported second-quarter 2025 revenue of $116.7 million, up 15.4% from a year earlier, and adjusted EBITDA of $29.7 million, up 49.2%. Net income attributable to Pursuit fell to $5.6 million from $29.3 million, a change the company attributes mainly to the 2024 sale of its GES business, and it also took a pre-tax pension termination charge of approximately $5.4 million. The company raised its full-year 2025 adjusted EBITDA guidance to $108 million to $118 million from $98 million to $108 million and approved a new share repurchase authorization of up to $50 million.
Q2 2025 revenue $116.7 million, up $15.5 million (15.4%) from $101.2 million
Net income attributable to Pursuit $5.6 million vs. $29.3 million; diluted EPS $0.20 vs. $0.98
Full-year 2025 adjusted EBITDA guidance raised to $108 million to $118 million, up $10 million
Board approved a new share repurchase authorization of up to $50 million on August 4, 2025
Realty Income reported second-quarter 2025 revenue of $1,410.4 million, up from $1,339.4 million a year earlier, but net income available to common stockholders fell to $196.9 million, or $0.22 per diluted share, from $256.8 million, or $0.29, as impairments of $143.4 million weighed on results. The company cut its 2025 net income per share guidance to $1.29-$1.33 from $1.40-$1.46, raised the low end of its AFFO per share guidance to $4.24-$4.28, and increased its 2025 investment volume guidance to approximately $5.0 billion from approximately $4.0 billion.
Total revenue was $1,410.4 million for the three months ended June 30, 2025, compared with $1,339.4 million a year earlier
Net income available to common stockholders was $196.9 million, or $0.22 per diluted share, versus $0.29 a year earlier; provisions for impairment were $143.4 million
2025 net income per share guidance was revised to $1.29-$1.33 from $1.40-$1.46; AFFO per share guidance is $4.24-$4.28 versus $4.22-$4.28 previously
2025 investment volume guidance was raised to approximately $5.0 billion from approximately $4.0 billion; the monthly dividend paid per share rose 3.7% to $0.806 in the quarter
Vir Biotechnology reported second-quarter 2025 results, with a net loss of $111.0 million, or $0.80 per share, compared with $138.4 million, or $1.02 per share, a year earlier. Revenue fell to $1.2 million from $3.1 million, and cash, cash equivalents and investments were $892.1 million at June 30, 2025, which the company says funds operations into mid-2027.
Net loss was $111.0 million ($0.80 per share) versus $138.4 million ($1.02 per share) in Q2 2024.
Total revenues were $1.2 million versus $3.1 million in Q2 2024.
Cash, cash equivalents and investments were $892.1 million at June 30, 2025, down about $127.7 million in the quarter, including $50.5 million of ECLIPSE milestone payments.
R&D expenses were $97.5 million versus $105.1 million, reflecting restructuring savings; the ECLIPSE registrational program in chronic hepatitis delta is fully underway.
Veracyte reported second-quarter 2025 total revenue of $130.2 million, up 14% year over year, and swung to a GAAP net loss of $1.0 million after a $20.5 million impairment tied to its French subsidiary. The company raised its full-year testing revenue guidance and initiated full-year total revenue guidance of $496 million to $504 million, which matters to shareholders because it signals higher expected sales while the one-time charge weighs on reported profit.
Q2 2025 total revenue was $130.2 million, up 14% from $114.4 million; testing revenue was $122.3 million, up 14%.
GAAP net loss was $1.0 million, compared with net income of $5.7 million in Q2 2024, including a $20.5 million impairment charge.
Full-year 2025 testing revenue guidance was raised to $477 million to $483 million from $470 million to $480 million; total revenue guidance is $496 million to $504 million.
Non-GAAP diluted EPS was $0.44, up from $0.30 a year earlier; adjusted EBITDA was $35.8 million, or 27.5% of revenue.
Kulicke and Soffa reported third-quarter fiscal 2025 net revenue of $148.4 million, down 18.3% from a year earlier, and a GAAP net loss of $3.3 million, or $(0.06) per diluted share. Non-GAAP net income was $3.8 million, or $0.07 per share. The company expects fourth-quarter net revenue of about $170 million, plus or minus $10 million, and non-GAAP diluted EPS of about $0.22, plus or minus 10%.
Q3 net revenue $148.4 million, down 18.3% year over year and down 8.4% from Q2 fiscal 2025
GAAP net loss $3.3 million, or $(0.06) per diluted share, versus net income of $12.3 million a year earlier
Non-GAAP net income $3.8 million, or $0.07 per diluted share; GAAP operating loss $6.1 million
Q4 fiscal 2025 outlook: net revenue about $170 million +/- $10 million; GAAP diluted EPS about $0.08 +/- 10%
Alpha and Omega Semiconductor reported fiscal fourth-quarter revenue of $176.5 million, up 9.4% from a year earlier, and guided fiscal first-quarter revenue to $183 million plus or minus $10 million. GAAP net loss widened to $77.1 million, or $2.58 per diluted share, mainly because of a $76.8 million impairment of its equity method investment, while non-GAAP diluted EPS was $0.02 versus $0.09 a year earlier.
Q4 revenue $176.5 million, up 9.4% year over year and 7.2% sequentially; GAAP gross margin 23.4% versus 25.7% a year earlier
GAAP net loss $77.1 million ($2.58 per diluted share) versus a $2.7 million loss ($0.09 per share) a year earlier, including a $76.8 million equity method investment impairment
Fiscal 2025 revenue $696.2 million versus $657.3 million; GAAP net loss $97.0 million ($3.30 per share) versus $11.1 million
MasterBrand signed a merger agreement with American Woodmark, under which American Woodmark shareholders would receive 5.150 MasterBrand shares for each share they own, with closing expected in early 2026 subject to shareholder and regulatory approvals. The same day, MasterBrand reported second quarter 2025 results in which net sales rose 8% but net income fell 18% and diluted EPS declined to $0.29 from $0.35, while it maintained its 2025 outlook.
Exchange ratio of 5.150 MasterBrand shares per American Woodmark share; implied pro forma equity value of $2.4 billion and enterprise value of $3.6 billion
Termination fees of $30.0 million payable by MasterBrand and $25.0 million payable by American Woodmark; $35.0 million reverse termination fee payable by MasterBrand in certain antitrust-related cases
Expected run-rate cost synergies of approximately $90 million by the end of year three; closing expected in early 2026
Q2 2025: net sales up 8% to $730.9 million; net income down 18% to $37.3 million; adjusted EBITDA flat at $105.4 million; 2025 outlook maintained
Pinnacle West reported second-quarter 2025 net income attributable to common shareholders of $192.6 million, or $1.58 per diluted share, down from $203.8 million, or $1.76, a year earlier, while operating revenues rose to $1.36 billion. The company blamed cooler weather than last year's record heat and said it continues to expect 2025 earnings of $4.40 to $4.60 per diluted share on a weather-normalized basis.
Q2 2025 net income attributable to common shareholders was $192.6 million, or $1.58 per diluted share, versus $203.8 million, or $1.76, in Q2 2024.
Q2 2025 operating revenues were $1.36 billion, compared with $1.31 billion in Q2 2024.
The company cited 15.4% fewer cooling degree-days in Q2 2025 than in Q2 2024; net income for the first half of 2025 was 14.8% lower than in the first half of 2024.
2025 EPS guidance was continued at $4.40 to $4.60 per diluted share on a weather-normalized basis.
Southwest Gas Holdings reported second quarter 2025 results on August 6, 2025, with a GAAP net loss of $12.9 million, compared with net income of $18.3 million a year earlier. The company said the decline was primarily due to income taxes tied to its sale of Centuri stock, while adjusted diluted EPS rose to $0.53 from $0.31 and it reaffirmed its 2025 Southwest Gas net income guidance of $265 million to $275 million. For shareholders, GAAP earnings and consolidated revenue fell, while Centuri share sales funded debt reduction of over $470 million.
Q2 2025 GAAP net loss of $12.9 million, or $0.18 per diluted share, versus net income of $18.3 million, or $0.25 per diluted share, in Q2 2024
Adjusted diluted EPS of $0.53 for Q2 2025 versus $0.31 for Q2 2024
Consolidated operating revenues of $1.12 billion versus $1.18 billion in Q2 2024
2025 Southwest Gas net income guidance of $265 million to $275 million reaffirmed
Avnet reported fourth-quarter fiscal 2025 sales of $5.6 billion, up 1.0% from a year earlier, but diluted EPS fell to $0.07 from $0.91 and adjusted diluted EPS fell to $0.81 from $1.22. For the full fiscal year, sales declined to $22.2 billion from $23.8 billion and diluted EPS fell to $2.75 from $5.43, while the company gave first-quarter fiscal 2026 sales guidance of $5.55 billion to $5.85 billion and adjusted EPS guidance of $0.75 to $0.85.
Q4 fiscal 2025 sales of $5.6 billion, up 1.0% year over year; Asia sales rose 17.6%, while EMEA fell 16.7%
Q4 GAAP operating income of $73.5 million, down 55.3% from $164.2 million; operating margin 1.3% vs 3.0%
Fiscal 2025 diluted EPS of $2.75 vs $5.43; adjusted diluted EPS of $3.44 vs $5.34
Choice Hotels reported second quarter 2025 total revenues of $426 million, down from $435 million, and net income of $81.7 million, down from $87.1 million, with diluted EPS of $1.75 versus $1.80. The company lowered its full-year 2025 GAAP net income and diluted EPS outlook and its domestic RevPAR outlook, while adjusted diluted EPS rose to $1.92 from $1.84, and it completed the $112 million purchase of the remaining 50% of Choice Hotels Canada in July.
Q2 2025 total revenues were $426 million versus $435 million; net income was $81.7 million versus $87.1 million
Adjusted diluted EPS was $1.92 versus $1.84 in Q2 2024; adjusted EBITDA was $165.0 million, up 2%
Full-year 2025 net income outlook cut to $261–$276 million from $275–$290 million; domestic RevPAR outlook cut to -3% to 0% from -1% to 1%
Acquired remaining 50% of Choice Hotels Canada in July for approximately $112 million
Griffon reported fiscal third-quarter revenue of $613.6 million, down 5%, and a net loss of $120.1 million, or $2.65 per share, which included a $217.2 million after-tax impairment of Hunter Fan goodwill and intangibles. The company cut its fiscal 2025 revenue expectation to $2.5 billion from $2.6 billion, citing weak Consumer and Professional Products demand, while keeping its segment adjusted EBITDA guidance at $575 million to $600 million.
Q3 revenue was $613.6 million, down 5% from $647.8 million a year earlier; Consumer and Professional Products revenue fell 16%.
Adjusted EBITDA rose 7% to $134.7 million; adjusted earnings per share were $1.50, up from $1.24.
Fiscal 2025 revenue guidance was lowered by $100 million to $2.5 billion, attributed to the CPP segment.
Year to date, free cash flow was $261 million and the company repurchased $113 million of stock.
Regal Rexnord reported second-quarter 2025 net sales of $1,496.1 million, down 3.3% from a year earlier, while GAAP diluted EPS rose to $1.19 from $0.94 and adjusted diluted EPS rose 8.3% to $2.48. The company narrowed its 2025 adjusted diluted EPS guidance to $9.70 to $10.30 and set a GAAP diluted EPS range of $4.50 to $5.10.
Q2 2025 net sales were $1,496.1 million, down 3.3% year over year and down 1.2% on an organic basis.
GAAP net income was $79.6 million versus $63.0 million a year earlier; adjusted EBITDA was $329.7 million versus $335.3 million excluding the divested Industrial Systems segment.
2025 adjusted diluted EPS guidance was narrowed to $9.70 to $10.30; GAAP diluted EPS guidance is $4.50 to $5.10.
A $400 million accounts receivable securitization facility, entered June 30, 2025, contributed $368.5 million of net proceeds used to repay bank loans.
Payoneer reported second quarter 2025 revenue of $260.6 million, up 9% year over year, with revenue excluding interest income at a record $202.3 million, up 16%. Net income fell 40% to $19.5 million, and diluted earnings per share were $0.05 versus $0.09 a year earlier. The company reinstated its 2025 guidance and raised its share repurchase authorization to $300 million, which runs through December 31, 2027.
Q2 2025 revenue $260.6 million, up 9% year over year; net income $19.5 million, down 40%; adjusted EBITDA $66.4 million, down 9%
2025 guidance reinstated: revenue $1,040 million to $1,060 million; adjusted EBITDA $260 million to $275 million
Share repurchase authorization increased to $300 million, effective August 6, 2025, running through December 31, 2027
Accelerated share repurchases of $33 million in the quarter at a weighted average price of $6.80
Gibraltar reported second-quarter 2025 results for continuing operations, with net sales up 13.1% to $309.5 million and adjusted diluted EPS up 10.8% to $1.13. GAAP diluted EPS from continuing operations was $0.99, down from $1.01, as acquisition integration costs weighed on GAAP net income. The company kept its full-year 2025 outlook, which shareholders can compare with the results for continuing operations after the planned Renewables sale.
Net sales were $309.5 million, up from $273.6 million, while GAAP net income fell 5.2% to $29.4 million, mainly due to acquisition integration-related costs.
Adjusted diluted EPS was $1.13, up 10.8% from $1.02; GAAP diluted EPS from continuing operations was $0.99 versus $1.01.
Full-year 2025 guidance for continuing operations calls for consolidated net sales of $1.15 billion to $1.20 billion and GAAP EPS of $3.67 to $3.91.
Operating cash flow was $44 million in the quarter, and the board approved a plan on June 30, 2025 to sell the Renewables business.
American Financial Group reported second-quarter 2025 results on August 5, 2025. Net earnings fell to $174 million ($2.07 per share) from $209 million ($2.49 per share), while total revenues rose to $1,924 million from $1,900 million, and core net operating earnings fell to $179 million ($2.14 per share) from $215 million ($2.56 per share). Shareholders receive the lower profit figures, though the company cited lower underwriting profit and weaker returns on alternative investments as the main drivers.
Net earnings of $174 million ($2.07 per share) vs. $209 million ($2.49 per share) in Q2 2024; total revenues $1,924 million vs. $1,900 million
Core net operating earnings of $179 million ($2.14 per share) vs. $215 million ($2.56 per share); annualized core operating ROE of 15.5% vs. 18.5%
Specialty P&C combined ratio of 93.1% vs. 90.5% a year earlier; alternative investments returned approximately 1.2% annualized vs. 5.1%
Capital returned to shareholders of approximately $107 million in Q2, including $39 million in share repurchases; book value per share was $54.15 at June 30, 2025
Vishay reported fiscal second-quarter 2025 revenue of $762.3 million, up from $741.2 million a year earlier and up 7% sequentially, but GAAP earnings per share fell to $0.01 from $0.17. Adjusted loss per share was $(0.07) after excluding an $11.3 million benefit from a favorable contingency resolution. The company guided third-quarter revenue to $775 million, plus or minus $20 million.
Q2 2025 revenue $762.3 million vs $741.2 million in Q2 2024; gross margin 19.5% vs 22.0%
GAAP diluted EPS $0.01 vs $0.17 a year earlier; adjusted loss per diluted share $(0.07)
Q3 2025 outlook: revenue of $775 million, plus or minus $20 million; gross margin 19.7%, plus or minus 50 basis points
Charles River reported second-quarter 2025 revenue of $1.03 billion, up 0.6% as reported but down 0.5% organically, and non-GAAP earnings per share of $3.12, up 11.4%. GAAP earnings per share fell to $1.06 from $1.74, mainly due to accelerated amortization and restructuring and legal costs. The company raised its full-year non-GAAP earnings per share guidance but lowered its GAAP earnings per share guidance.
Q2 revenue was $1,032.1 million, up 0.6% reported and down 0.5% organic; DSA segment organic revenue fell 2.4%.
Q2 GAAP net income available to common shareholders was $52.3 million, or $1.06 per share, versus $90.0 million, or $1.74 per diluted share, a year earlier.
2025 non-GAAP EPS guidance was raised to $9.90-$10.30 from $9.30-$9.80; GAAP EPS guidance was lowered to $4.25-$4.65 from $4.35-$4.85.
The company said the U.S. Department of Justice had closed the grand jury and parallel civil investigations into its NHP shipments.
Diebold Nixdorf reported second-quarter 2025 revenue of $915.2 million, down 2.6% from $939.7 million a year earlier, and GAAP net income of $12.7 million, down from $14.8 million. The company reaffirmed its full-year 2025 outlook and said it is trending toward the higher end of the range, while free cash flow improved to $12.6 million from negative $16.1 million.
Q2 revenue of $915.2 million, down 2.6% year over year but up about 9% sequentially from Q1 2025
GAAP net income of $12.7 million and diluted EPS of $0.33, versus $14.8 million and $0.40 a year earlier; adjusted EBITDA of $111.2 million, down from $118.8 million
Free cash flow of $12.6 million versus negative $16.1 million a year earlier; about $30 million of shares repurchased in Q2 and $38 million year to date under the $100 million program
2025 guidance reaffirmed: adjusted EBITDA $470 million to $490 million and free cash flow $190 million to $210 million, while monitoring global tariff policies
CDW reported second quarter 2025 results on August 6, 2025, with net sales up 10.2% to $5.98 billion, while GAAP operating income fell 3.0% to $420 million and GAAP net income fell 3.5% to $271 million. Non-GAAP net income per diluted share rose 3.9% to $2.60, and the Board declared a $0.625 quarterly dividend payable September 10, 2025.
Net sales were $5.98 billion, up 10.2% from $5.42 billion in the second quarter of 2024.
Gross profit margin fell to 20.8% from 21.8%, and operating income declined 3.0% to $420 million.
Diluted net income per share was $2.05, down 1.2% from $2.07; non-GAAP diluted EPS was $2.60, up 3.9% from $2.50.
The quarterly dividend is $0.625 per share, payable September 10, 2025, to holders of record on August 25, 2025.
Global Payments reported second quarter 2025 results, with adjusted diluted EPS up 11% to $3.10 while GAAP diluted EPS fell 32.7% to $0.99 and GAAP revenue fell 0.7% to $1.96 billion. The company now expects 2025 adjusted EPS growth at the high end of its 10% to 11% range and reaffirmed 5% to 6% constant currency adjusted net revenue growth, excluding dispositions, while planning a $500 million accelerated share repurchase.
GAAP diluted EPS was $0.99 versus $1.47 a year earlier; adjusted diluted EPS was $3.10 versus $2.80, up 10.7%.
GAAP revenue was $1.96 billion, down 0.7%; adjusted net revenue was $2.36 billion, up 1.6%.
Adjustments included a $33.2 million noncash goodwill impairment tied to the Issuer Solutions divestiture.
Worldpay acquisition and Issuer Solutions divestiture cleared HSR review and remain on track to close in the first half of 2026.
Astec reported second quarter 2025 net income of $16.7 million, or $0.72 per diluted share, compared with a net loss of $14.0 million a year earlier, while net sales fell 4.4% to $330.3 million. The company raised the low end of its core full-year adjusted EBITDA guidance and expects the TerraSource acquisition, completed July 1, 2025, to add $13 million to $17 million, bringing consolidated guidance to $123 million to $142 million.
Q2 net sales of $330.3 million, down 4.4% from $345.5 million in Q2 2024
Q2 net income of $16.7 million ($0.72 diluted EPS) versus a $14.0 million net loss ($0.61 loss per share) a year earlier
Q2 adjusted EBITDA of $33.7 million versus $27.6 million; core full-year adjusted EBITDA guidance low end raised from $105 million to $110 million, top end kept at $125 million
TerraSource acquisition completed July 1, 2025; company expects $13 million to $17 million of adjusted EBITDA from it, for consolidated guidance of $123 million to $142 million
NRG reported a second-quarter 2025 GAAP net loss of $104 million, compared with net income of $738 million a year earlier, driven mainly by non-cash mark-to-market hedge losses and a higher legal reserve. Adjusted EPS rose to $1.73 from $1.70, while Adjusted EBITDA fell $53 million, and the company reaffirmed its 2025 guidance, saying it is trending toward the upper end of its ranges.
Q2 2025 GAAP net loss of $104 million, or $(0.62) per basic share, versus net income of $738 million in Q2 2024.
Adjusted EPS of $1.73, up $0.03 year over year; Adjusted Net Income of $339 million, down $14 million; Adjusted EBITDA of $909 million, down $53 million.
2025 guidance reaffirmed: Adjusted EPS of $6.75 to $7.75 and Adjusted EBITDA of $3,725 million to $3,975 million.
Revenue of $6,740 million, up from $6,659 million a year earlier; 295 MW of data center retail agreements signed.
Iron Mountain reported record second-quarter 2025 revenue of $1.7 billion, up 11.6% from a year earlier, and raised its full-year 2025 guidance. The company posted a net loss of $43 million, compared with net income of $35 million in the second quarter of 2024, which it attributed to changes in exchange rates on intercompany balances. The guidance increase and higher adjusted measures point to stronger operations, while the GAAP swing to a loss is a notable offset for shareholders.
Q2 2025 total revenues were $1.7 billion, up 11.6% reported and 11.0% excluding foreign exchange.
Q2 2025 net loss was $43 million, or $(0.15) per diluted share, versus net income of $35 million in Q2 2024.
Adjusted EBITDA rose 15.4% to $628 million; adjusted EPS was $0.48, up from $0.42.
Full-year 2025 total revenue guidance was raised to $6,790 million to $6,940 million, from $6,740 million to $6,890 million.
Fortrea reported second-quarter 2025 revenue of $710.3 million, up from $662.4 million a year earlier, and raised its 2025 revenue guidance to $2.6 billion to $2.7 billion. The company also posted a GAAP net loss of $374.9 million, which included a $309.1 million non-cash goodwill impairment, and it affirmed 2025 adjusted EBITDA guidance of $170 million to $200 million. The new CEO, Anshul Thakral, joined on August 4, 2025.
Q2 revenue was $710.3 million, compared with $662.4 million in Q2 2024.
GAAP net loss was $374.9 million, or $(4.14) per diluted share, including a $309.1 million goodwill impairment charge.
Adjusted diluted EPS was $0.19, compared with $(0.03) a year earlier; adjusted EBITDA was $54.9 million versus $55.2 million.
2025 revenue guidance raised to $2.6 billion to $2.7 billion; adjusted EBITDA guidance of $170 million to $200 million affirmed.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.